Inhalable Particulate Delivery

Inhalable Particulate Delivery is a drug delivery system that administers therapeutic agents in particulate form via the pulmonary route, distinguished by its reliance on precisely engineered particle size and aerodynamic properties to enable deep lung deposition and controlled release.

42

Publications

2.3K

Citations

220

Authors

101

Institutions

Publications per year

2017–2026

11

Authors

220

  1. JG
    Jeffry G. Weers

    Alliance Pharmaceutical (United States), United States

    2 publications · 328 citations

    2

    h-index

  2. LW
    Li Wu

    Chinese Academy of Sciences, China

    2 publications · 140 citations

    2

    h-index

  3. TE
    Thomas E. Tarara

    Alliance Pharmaceutical (United States), United States

    2 publications · 328 citations

    2

    h-index

  4. PA
    Paul A. Charpentier

    Western University, Canada

    2 publications · 91 citations

    2

    h-index

  5. CW
    Caifen Wang

    Chinese Academy of Sciences, China

    2 publications · 140 citations

    2

    h-index

1–5 of 220

Venues

  1. Pharmaceutical Research

    3 publications · 340 citations

    3

    h-index

  2. International Journal of Pharmaceutics

    3 publications · 188 citations

    3

    h-index

  3. Journal of Controlled Release

    3 publications · 298 citations

    3

    h-index

  4. Advanced Drug Delivery Reviews

    2 publications · 203 citations

    2

    h-index

  5. European Journal of Pharmaceutical Sciences

    2 publications · 48 citations

    2

    h-index

1–5